MarketCap
Facebook
X
Telegram
IMARA EV - Enterprise Value | IMRA
Annual EV - Enterprise Value IMARA
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -82.3 M | -108 M | 150 M | -48.8 M | -100 M | 183 M | -642 K | 34 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 183 M | -108 M | 3.38 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Sarepta Therapeutics
SRPT
|
3.05 B | $ 17.8 | 0.68 % | $ 1.78 B |  USA |
 |
Paratek Pharmaceuticals
PRTK
|
390 M | - | - | $ 121 M | USA |
 |
China SXT Pharmaceuticals
SXTC
|
-22 M | $ 2.84 | -3.07 % | $ 1.93 M |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
6.95 T | $ 21.02 | -0.92 % | $ 33.2 B |  Japan |
 |
Tarsus Pharmaceuticals
TARS
|
2.95 B | $ 68.11 | 0.87 % | $ 2.85 B | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
16.7 M | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Bio-Techne Corporation
TECH
|
11 B | $ 72.78 | 0.17 % | $ 11.4 B | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
70.6 B | $ 42.32 | 1.33 % | $ 48.5 B |  Israel |
 |
RedHill Biopharma Ltd.
RDHL
|
24 B | $ 0.43 | 0.45 % | $ 5.3 B | Israel |
 |
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | USA |
 |
Unity Biotechnology
UBX
|
51.7 M | - | -33.41 % | $ 3.37 M | USA |
 |
iTeos Therapeutics
ITOS
|
248 M | - | - | $ 411 M | USA |
 |
Shattuck Labs
STTK
|
304 M | $ 4.59 | 2.78 % | $ 319 M | USA |
 |
Seelos Therapeutics
SEEL
|
41.4 M | - | -47.76 % | $ 6.27 M | USA |
 |
Evogene Ltd.
EVGN
|
1.49 M | $ 0.28 | -16.14 % | $ 2.2 M | Israel |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Protara Therapeutics
TARA
|
208 M | $ 2.33 | 9.15 % | $ 99.8 M | USA |
 |
Trevi Therapeutics
TRVI
|
1.5 B | $ 14.33 | 11.87 % | $ 1.93 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
-795 K | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Fennec Pharmaceuticals
FENC
|
167 M | $ 9.79 | 4.26 % | $ 280 M | USA |
 |
Kiromic BioPharma
KRBP
|
24.8 M | - | 6.61 % | $ 3.08 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
-2.04 M | $ 3.92 | -2.24 % | $ 1.74 M | USA |
 |
Calithera Biosciences
CALA
|
-17.2 M | - | -10.95 % | $ 876 K | USA |
 |
United Therapeutics Corporation
UTHR
|
22.8 B | $ 562.14 | -0.63 % | $ 24.9 B | USA |
 |
Vericel Corporation
VCEL
|
1.92 B | $ 54.56 | 5.36 % | $ 2.75 B | USA |
 |
Veracyte
VCYT
|
2.78 B | $ 24.1 | 0.42 % | $ 1.89 B | USA |
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Fulcrum Therapeutics
FULC
|
359 M | $ 3.72 | 0.95 % | $ 236 M | USA |
 |
Molecular Templates
MTEM
|
29.7 M | - | -23.43 % | $ 495 K | USA |
 |
Vanda Pharmaceuticals
VNDA
|
435 M | $ 3.82 | 6.27 % | $ 225 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
58.9 M | $ 3.22 | 4.21 % | $ 34.3 M | USA |
 |
Viridian Therapeutics
VRDN
|
2.95 B | $ 28.47 | -0.28 % | $ 2.9 B | USA |
 |
BioXcel Therapeutics
BTAI
|
127 M | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
VistaGen Therapeutics
VTGN
|
3.96 M | $ 0.17 | 3.45 % | $ 6.47 M | USA |
 |
Voyager Therapeutics
VYGR
|
232 M | $ 1.86 | 8.14 % | $ 109 M | USA |
 |
CohBar
CWBR
|
410 K | - | -15.44 % | $ 2.2 M | USA |
 |
NeuBase Therapeutics
NBSE
|
-3.75 M | - | -1.56 % | $ 12.3 M | USA |
 |
Gossamer Bio
GOSS
|
365 M | $ 9.77 | 3.72 % | $ 2.23 B | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
1.24 B | - | - | $ 2.18 B | USA |
 |
GeoVax Labs
GOVX
|
658 K | $ 0.16 | -5.0 % | $ 153 K | USA |
 |
Arena Pharmaceuticals
ARNA
|
5.42 B | - | -6.81 % | $ 3.04 B | USA |
 |
Scopus BioPharma
SCPS
|
3.67 M | - | -48.37 % | $ 3.71 M | USA |
 |
Annovis Bio
ANVS
|
36.5 M | $ 0.82 | 23.72 % | $ 16.9 M | USA |
 |
scPharmaceuticals
SCPH
|
18.5 M | - | - | $ 218 M | USA |
 |
Xeris Pharmaceuticals
XERS
|
1.23 B | $ 15.08 | 15.29 % | $ 2.42 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
66 M | $ 3.15 | 2.61 % | $ 133 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
51.1 M | - | - | $ 105 M | USA |
 |
Athersys
ATHX
|
-9.04 M | - | 3.77 % | $ 22.4 M | USA |
 |
Zai Lab Limited
ZLAB
|
21.4 B | $ 25.49 | 12.77 % | $ 27.9 B | China |
 |
Zentalis Pharmaceuticals
ZNTL
|
229 M | $ 1.71 | 2.05 % | $ 123 M | USA |